Endocarditis Heather Patterson PGY-2 Emerg June 6 2007.
-
Upload
delphia-francis -
Category
Documents
-
view
217 -
download
0
Transcript of Endocarditis Heather Patterson PGY-2 Emerg June 6 2007.
![Page 1: Endocarditis Heather Patterson PGY-2 Emerg June 6 2007.](https://reader031.fdocuments.in/reader031/viewer/2022013012/56649f4e5503460f94c6f86d/html5/thumbnails/1.jpg)
Endocarditis
Heather Patterson
PGY-2 EmergJune 6 2007
![Page 2: Endocarditis Heather Patterson PGY-2 Emerg June 6 2007.](https://reader031.fdocuments.in/reader031/viewer/2022013012/56649f4e5503460f94c6f86d/html5/thumbnails/2.jpg)
Objectives
• History and Epidemiology• Pathophysiology• Risk Factors• Duke Criteria• Management
![Page 3: Endocarditis Heather Patterson PGY-2 Emerg June 6 2007.](https://reader031.fdocuments.in/reader031/viewer/2022013012/56649f4e5503460f94c6f86d/html5/thumbnails/3.jpg)
History
• 1825: First described • 1846: Realized vegetations where
bacterial• 1932-40: Supportive treatment until this
time when ABx first used
![Page 4: Endocarditis Heather Patterson PGY-2 Emerg June 6 2007.](https://reader031.fdocuments.in/reader031/viewer/2022013012/56649f4e5503460f94c6f86d/html5/thumbnails/4.jpg)
Epidemiology
• 10,000-50,000 new cases per year in US• Mean age 55y• M:F = 2:1 – 9:1• Rheumatic heart disease less common
than nosocomial, prosthetic valve, IVDU
![Page 5: Endocarditis Heather Patterson PGY-2 Emerg June 6 2007.](https://reader031.fdocuments.in/reader031/viewer/2022013012/56649f4e5503460f94c6f86d/html5/thumbnails/5.jpg)
Epidemiology
• Native Valve:– >50yo– M>F– 60-80% with predisposing cardiac disease– Staph aureus in 50-60%
![Page 6: Endocarditis Heather Patterson PGY-2 Emerg June 6 2007.](https://reader031.fdocuments.in/reader031/viewer/2022013012/56649f4e5503460f94c6f86d/html5/thumbnails/6.jpg)
Epidemiology
• IVDU:– 20% have
abnormal underlying valve pathology
– R vs L
![Page 7: Endocarditis Heather Patterson PGY-2 Emerg June 6 2007.](https://reader031.fdocuments.in/reader031/viewer/2022013012/56649f4e5503460f94c6f86d/html5/thumbnails/7.jpg)
Pathophysiology
• Thrombus formation:– Subacute - often
thrombus is preexisting or damage to valve is preexisting
– Acute – bacteria can cause thrombus, +/- prior valve damage, rapid progression
• Organism Adherence– Circulating
bacteria/fungus adhere and colonize
– Accelerated plt aggregation
– Platelets coat and protect bacteria from immune response
![Page 8: Endocarditis Heather Patterson PGY-2 Emerg June 6 2007.](https://reader031.fdocuments.in/reader031/viewer/2022013012/56649f4e5503460f94c6f86d/html5/thumbnails/8.jpg)
Pathophysiology
• Valve Invasion:– Immune response
damages valve leaflets, chordae tendinae
• Systemic effects:– Infectious
microemboli• CNS• Myocardium• Renal• Pulmonary
– Vasculitis
![Page 9: Endocarditis Heather Patterson PGY-2 Emerg June 6 2007.](https://reader031.fdocuments.in/reader031/viewer/2022013012/56649f4e5503460f94c6f86d/html5/thumbnails/9.jpg)
Microorganisms
• Congenital valve disease & MVP:– Strep viridans– Strep milleri
• IVDU & prosthetic valves– Coag neg staph
• Other– Gram neg bacilli
• HACEK—haemophilus, actinobacillus, cardiobacterium, eikenella, kingella
– Candida– Aspergillus
![Page 10: Endocarditis Heather Patterson PGY-2 Emerg June 6 2007.](https://reader031.fdocuments.in/reader031/viewer/2022013012/56649f4e5503460f94c6f86d/html5/thumbnails/10.jpg)
Risk Factors
• IVDU– R vs L sided?– Recurrence up to
40%
• Prosthetic heart valves– First yr- 1-4%
develop IE– 0.5-4% risk each
subsequent year– Type of valve not a
determinant of risk
• Pacemakers/ICDs
• Indwelling caths
• History of IE– 2.5-9% of pts recur
![Page 11: Endocarditis Heather Patterson PGY-2 Emerg June 6 2007.](https://reader031.fdocuments.in/reader031/viewer/2022013012/56649f4e5503460f94c6f86d/html5/thumbnails/11.jpg)
Risk Factors
• Structural heart disease– Up to ¾ of all IE have structural disease
present at the time of diagnosis– Rheumatic:
• Older studies show this is the most common
– Mitral value prolapse with regurgitation• 5-8x the risk of general population• Reported in 22-29% of cases
– Aortic valve disease• Reported in 12-30% of cases
![Page 12: Endocarditis Heather Patterson PGY-2 Emerg June 6 2007.](https://reader031.fdocuments.in/reader031/viewer/2022013012/56649f4e5503460f94c6f86d/html5/thumbnails/12.jpg)
Risk Factors
• Congenital Heart Disease– Seen in 10-20% of IE cases– Most common lesions:
• Bicuspid aortic valve• PDA• VSD• Coarctation• TOF
![Page 13: Endocarditis Heather Patterson PGY-2 Emerg June 6 2007.](https://reader031.fdocuments.in/reader031/viewer/2022013012/56649f4e5503460f94c6f86d/html5/thumbnails/13.jpg)
Risk Factors
• 2401 pts followed for 40,000 days• Rates of IE in patients with AS, PS, VSD• Results:
– Overall incidence was 35x the general population rate
– AS• Risk increased with gradient across the valve
– PS:• Lowest risk of the conditions studied. (1/592
patients)
– VSD• Size of defect not related to risk of IECirculation 1993 Feb;87(2 Suppl):I121-6.
![Page 14: Endocarditis Heather Patterson PGY-2 Emerg June 6 2007.](https://reader031.fdocuments.in/reader031/viewer/2022013012/56649f4e5503460f94c6f86d/html5/thumbnails/14.jpg)
Duke Criteria
• Any one of the following:– Direct evidence of IE on histologic exam– Gram stain/cultures of specimens– Two major criteria– One major and 3 minor criteria– Five minor criteria
![Page 15: Endocarditis Heather Patterson PGY-2 Emerg June 6 2007.](https://reader031.fdocuments.in/reader031/viewer/2022013012/56649f4e5503460f94c6f86d/html5/thumbnails/15.jpg)
Duke Criteria
• Major criteria– Positive blood cultures
x2 (12 hours apart)• Strep viridans• Strep bovis• HACEK group• Community acquired
Staph or entercoccus
– Persistent bacteremia by cultures >12h apart
![Page 16: Endocarditis Heather Patterson PGY-2 Emerg June 6 2007.](https://reader031.fdocuments.in/reader031/viewer/2022013012/56649f4e5503460f94c6f86d/html5/thumbnails/16.jpg)
Duke Criteria
• Major criteria– Evidence of endocardial
involvement with new murmur
• Single positive culture for Coxiella burnetti OR Antiphase 1 IgG Ab titre >1:800
![Page 17: Endocarditis Heather Patterson PGY-2 Emerg June 6 2007.](https://reader031.fdocuments.in/reader031/viewer/2022013012/56649f4e5503460f94c6f86d/html5/thumbnails/17.jpg)
Duke Criteria
• Major criteria– Positive ECHO
• Oscillating intracardiac mass on valve or supporting structures, regurgitant jets or prosthetic material
• New partial detachment of prosthetic valve
• New valvular regurgitation or increase or change
• Abscess
NOTE: TEE recommended for prosthetic valves
![Page 18: Endocarditis Heather Patterson PGY-2 Emerg June 6 2007.](https://reader031.fdocuments.in/reader031/viewer/2022013012/56649f4e5503460f94c6f86d/html5/thumbnails/18.jpg)
Duke Criteria
• Minor criteria– Predisposing cardiac disease– IVDU– Fever>38– Vascular phenomena
• Arterial emboli• Septic pulmonary infaracts• Mycotic aneurysms• Intracranial hemorrhage• Conjunctival hemorrhage• Janeway lesions
![Page 19: Endocarditis Heather Patterson PGY-2 Emerg June 6 2007.](https://reader031.fdocuments.in/reader031/viewer/2022013012/56649f4e5503460f94c6f86d/html5/thumbnails/19.jpg)
Duke Criteria
• Minor criteria– Immune phenomena
• Osler’s nodes• Roth spots• Positive rheumatoid factor• Glomerulonephritis
– Microbiological evidence• Positive culture not meeting major criteria• Serologic evidence of active infection with organism
that causes IE
– ECHO• Non diagnostic but abnormal
![Page 20: Endocarditis Heather Patterson PGY-2 Emerg June 6 2007.](https://reader031.fdocuments.in/reader031/viewer/2022013012/56649f4e5503460f94c6f86d/html5/thumbnails/20.jpg)
Duke Criteria
• Sensitivity: 99%• Specificity: 95%
![Page 21: Endocarditis Heather Patterson PGY-2 Emerg June 6 2007.](https://reader031.fdocuments.in/reader031/viewer/2022013012/56649f4e5503460f94c6f86d/html5/thumbnails/21.jpg)
Clinical Presentation
• Most often nonspecific and varied presentation– High index of
suspicion
• Classic triad:– Fever– Anemia – Murmur
• Most common symptoms:– Intermittent fever
(85%)– Malaise (95%)
• Others: – Weakness,
anorexia, myalgias
– SOB, CP, cough, – HA, neuro
symptoms
![Page 22: Endocarditis Heather Patterson PGY-2 Emerg June 6 2007.](https://reader031.fdocuments.in/reader031/viewer/2022013012/56649f4e5503460f94c6f86d/html5/thumbnails/22.jpg)
Investigations
• CBC– Leukocytosis– Mild anemia
• Elevated ESR, CRP• Blood culture x 3-4 • U/A:
– microscopic hematuria (secondary to emboli)
• EKG– conduction
abnormality possible if abscess develops
• ECHO– TTE: Native valve– TEE: Recommended
for prosthetic valves• superior to TTE; NPV
95%
![Page 23: Endocarditis Heather Patterson PGY-2 Emerg June 6 2007.](https://reader031.fdocuments.in/reader031/viewer/2022013012/56649f4e5503460f94c6f86d/html5/thumbnails/23.jpg)
Management
Vanco 15mg/kg then 500mg q6h
AND
Gent 1-3mg/kg then 1mg/kg q8h
Ceftriaxone 1-2g q12h AND
Gent 1-3mg/kg then 1mg/kg q8h
OR
![Page 24: Endocarditis Heather Patterson PGY-2 Emerg June 6 2007.](https://reader031.fdocuments.in/reader031/viewer/2022013012/56649f4e5503460f94c6f86d/html5/thumbnails/24.jpg)
Management
• Surgical Indications:– Severe CHF due to valve incompetence– Paravalvular leak around prosthetic valve– Fungal endocarditis– Persistent bacteremia despite abx